Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,589 | Dovepress* | 10,556+ | 2,146 | 12,702 | |
PubMed Central* | 2,033 | 429 | 2,462 | ||
Totals | 12,589 | 2,575 | 15,164 | ||
*Since 24 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar